Sarepta Therapeutics, Inc. (SRPT) › Cash & EquivalentsSarepta Therapeutics, Inc. (SRPT) — Cash & EquivalentsAnnual figures by period end, from SEC filings.1980-07-21: $02008-12-31: $11.19M2009-12-31: $48.27M2010-12-31: $33.59M2011-12-31: $39.90M2012-12-31: $187.66M2013-12-31: $256.96M2014-12-31: $73.55M2015-12-31: $80.30M2016-12-31: $122.42M2017-12-31: $599.69M2018-12-31: $370.83M2019-12-31: $835.08M2020-12-31: $1.50B2021-12-31: $2.12B2022-12-31: $966.78M2023-12-31: $428.43M2024-12-31: $1.10B2025-12-31: $801.28M$801.28M1980-07-21Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$801.28M-27.4%2026-03-02Balance as of period end2024-12-31$1.10B+157.5%2026-03-02Balance as of period end2023-12-31$428.43M-55.7%2026-03-02Balance as of period end2022-12-31$966.78M-54.3%2025-02-28Balance as of period end2021-12-31$2.12B+40.8%2024-02-28Balance as of period end2020-12-31$1.50B+79.9%2023-02-28Balance as of period end2019-12-31$835.08M+125.2%2022-03-01Balance as of period end2018-12-31$370.83M-38.2%2021-03-01Balance as of period end2017-12-31$599.69M+389.9%2020-02-26Balance as of period end2016-12-31$122.42M+52.4%2019-02-28Balance as of period end2015-12-31$80.30M+9.2%2017-02-28Balance as of period end2014-12-31$73.55M-71.4%2017-02-28Balance as of period end2013-12-31$256.96M+36.9%2017-02-28Balance as of period end2012-12-31$187.66M+370.3%2016-02-25Balance as of period end2011-12-31$39.90M+18.8%2015-02-26Balance as of period end2010-12-31$33.59M-30.4%2014-03-03Balance as of period end2009-12-31$48.27M+331.3%2013-03-15Balance as of period end2008-12-31$11.19M—2012-03-13Balance as of period end1980-07-21$0—2013-03-15Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)